Cite
HARVARD Citation
Papadavid, E. et al. (2021). Multicentric EORTC retrospective study shows efficacy of brentuximab vedotin in patients who have mycosis fungoides and Sézary syndrome with variable CD30 positivity. British journal of dermatology. pp. 1035-1044. [Online].